Abstract

Background: Pneumonia is a severe infection that attacks lung tissue and is caused by bacteria, viruses or fungi. The incidence of Drug Related Problems (DRPs) in pneumonia can affect treatment outcomes leading to increased mortality and morbidity. Objective: To determine DRPs in pneumonia patients hospitalised at the Jasa Kartini Hospital (RSJK) Tasikmalaya City. Method: A descriptive observational study with retrospective data collection and consecutive sampling was conducted from January - December 2021. Demographic, quantitative, and DRPs data analysis with the number of patients who met the inclusion criteria (n = 69). Result: Based on demographics, pneumonia mostly affects elderly patients (> 65 years) by 29.0%, female (52.2%), housewife work (34.8%) with Length Of Stay between five and six days (42.0%), diagnosis of pneumonia with comorbidities (73.9%), as well as payment status using private payment (43.5%). Based on quantitative analysis, the most widely used drugs were non-generic drugs (70.1%) and antibiotics (18.2%). Drug Related Problems (DRPs) as many as 50 cases with an category indication without drugs 11 cases (22.0%) which include indications of pulmonary tuberculosis, diarrhea, and hypertension; drugs without indication 0 cases; underdose in eight cases (16.0%) which included Analsik, Largactil, Alganax, Sanmol, Ketorolac, Risperidon, ranitidine; drug overdose in 12 cases (24.0%) which included Tracetat, Sanmol Syrup, Codipront, Citicolin, Lansoprazole, Lancid, Furosemid; wrong drug 0 cases, drug interaction 19 cases (38.0%) with major (10.5%), moderate (68.4%) and minor (21.1%) categories; and adverse drugs 0 cases. Conclusion: Several treatments for pneumonia patients at the Tasikmalaya City Hospital for the period January to December 2021 experienced DRPs.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call